Today: 23 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

Axsome Therapeutics shares closed at $151.20 on Monday, near record highs, after reporting 63% year-over-year revenue growth in Q3 2025 to $171 million. The stock has climbed over 50% in the past year, valuing the company at about $7.6 billion. Net loss for the quarter narrowed to $47.2 million, or –$0.94 per share. Trading volume on Monday was roughly 540,000 shares.
25 November 2025
·
ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Altimmune shares traded near $5.10 on November 25, up about 20% over two weeks after Phase 2b data for lead drug pemvidutide was published in The Lancet and highlighted at AASLD. The stock remains down over 50% from its December 2024 high, with investor sentiment tempered by ongoing shareholder lawsuits and a new $400 million shelf registration.
25 November 2025
··
Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Rheinmetall AG shares closed at €1,443.00 on Monday, down 5% and nearly 20% below early November highs, amid heavy trading volumes. The drop follows renewed hopes for peace in Ukraine, prompting investors to exit defense stocks. Despite the sell-off, Rheinmetall confirmed record order books and strong 2025 guidance. The stock remains up about 150% year-to-date.
25 November 2025
··
SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Sarepta shares closed Monday at $18.90, up 6.9%, after a positive safety update for its experimental RNA therapy SRP‑1003. The company hit an enrollment milestone in its DM1 trial, triggering a $200 million payment to Arrowhead Pharmaceuticals. SRPT stock remains down about 85% year-to-date following setbacks with its gene therapy Elevidys.
25 November 2025
····
RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. shares closed at $6.51 Monday, up 14.4% on heavy volume after Tether boosted its stake by 1.06 million shares and agreed to buy up to $150 million in GPU services. The stock has surged over 22% in two sessions but remains near the bottom of its 52-week range. Market cap stands near $2.5 billion.
25 November 2025
····
NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital (NASDAQ: NUAI) closed Monday at $4.40, up 15.8% after announcing its Texas AI data center campus will expand to 438 acres. Trading volume reached 8.6 million shares. Despite the rally, NUAI shares remain down about 62% over the past year. The company reported $0.84 million in revenue and a $23.5 million net loss for the past 12 months.
25 November 2025
···
Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s named Michael J. Bender as permanent CEO on November 24, making him the fourth chief since 2018. Shares traded near $15.70 early Tuesday, valuing the company at about $1.8 billion, ahead of third-quarter earnings expected to show a loss and declining sales. Short interest stands at roughly 26–27% of float. The board declared a $0.125 per share dividend, payable December 24.
25 November 2025
··
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell shares closed Monday at $127.22, up 3.8%, but remain down nearly 20% for the month and about 24% below their early-November high. Wall Street expects Q3 revenue near $27.2 billion and non-GAAP EPS around $2.48. Options imply a 9% post-earnings move. Project Maverick, Dell’s internal overhaul, faces a three-month delay due to scalability issues.
25 November 2025
····
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics closed at $34.65 on November 24, valuing the company at about $3.9 billion. The firm completed enrollment in its Phase 3 obesity trial VANQUISH-1 ahead of schedule, with its lead drug VK2735 now in late-stage testing. Shares remain volatile, trading far below their 52-week high of $56.25 but well above the low of $18.92. Viking has no approved products or product revenue.
25 November 2025
··
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer shares traded near $25 late Monday, valuing the company at about $143 billion, with a dividend yield of roughly 6.8%. Q3 2025 revenue fell 6% to $16.7 billion, as COVID product sales declined sharply, but non-COVID portfolio sales rose 4%. Adjusted EPS of $0.87 beat expectations by over 30%. Pfizer reaffirmed 2025 revenue guidance and raised its adjusted EPS outlook.
25 November 2025
·
TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals shares fell 11% to close at $14.29 on Monday, despite receiving FDA clearance to advance its depression drug TNX-102 SL into Phase 2 trials. The stock sits near the bottom of its 52-week range after sharp volatility and recent expansion of its at-the-market stock offering program. Tonix recently launched Tonmya for fibromyalgia and reported $190.1 million in cash for Q3 2025.
25 November 2025
·
Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu shares jumped 7.5% to $119 on November 25 after JP Morgan upgraded the stock to “Overweight” and raised its price target to $188. The rally followed a mixed Q3 report showing revenue fell 7% to RMB 31.2 billion, with continued growth in AI and cloud offsetting weakness in advertising. Institutional investors, including Sierra Summit Advisors, increased positions in recent months.
25 November 2025
··
Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy shares fell 1.1% to $75.62 Monday, underperforming major indexes, with trading volume spiking to nearly 7 million shares ahead of Tuesday’s earnings report. Wall Street expects Q3 EPS of $1.31 on $9.6 billion revenue. The stock yields about 5% and trades at 21 times trailing earnings. Holiday sales forecasts remain weak, and tariffs continue to pressure margins.
25 November 2025
·
Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics shares closed at C$5.39 on November 24, up C$0.03, after reporting record Q3 revenue of C$31.3 million, a 60% year-over-year increase. Trading volume surged to 2.87 million shares, well above average. Gross profit rose 81% to C$18.6 million, with gross margin improving to 59%. The company reaffirmed its full-year outlook.
25 November 2025
··
MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

Medical Properties Trust (NYSE: MPW) closed Monday at about $5.31 per share, little changed after announcing a 12.5% dividend increase and a $150 million buyback. The REIT’s stock is up 25% over the past year but remains down more than 50% from three years ago. Average volume slightly exceeded normal at 8.6 million shares. Market cap stands near $3.2 billion.
24 November 2025
···
1 … 706 707 708 709 710 … 715

Stock Market Today

  • VTI ETF: Comprehensive Guide to Vanguard Total Stock Market ETF for Australian Investors
    March 23, 2026, 11:05 AM EDT. The Vanguard Total Stock Market ETF (VTI) offers broad U.S. equity market exposure, covering large-, mid-, and small-cap stocks. Australians can invest directly via the NYSE Arca listing or through the ASX cross-listed VTS, which provides the same exposure without U.S. administrative and tax complexities. VTI tracks the CRSP US Total Market Index and carries a low management fee of 0.03% annually, with over 3,500 holdings and a fund size exceeding US$570 billion. Investors should note VTI is U.S.-domiciled and unhedged to AUD, meaning currency risk applies. For those seeking solely S&P 500 exposure in an Australian wrapper, IVV is a suitable alternative. VTS remains the preferred ASX-listed choice for broad U.S. market exposure without direct U.S. market trading.
Go toTop